D. Carpenter

发表

Whose deaths matter? Mortality, advocacy, and attention to disease in the mass media.

E. Armstrong, D. Carpenter, Marie Hojnacki, 2006, Journal of health politics, policy and law.

Adaptive Signal Processing, Hierarchy, and Budgetary Control in Federal Regulation

D. Carpenter, 1996, American Political Science Review.

The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect.

M. Cowen, A. Fendrick, D. Carpenter, 2003, Archives of internal medicine.

Lessons for the Financial Sector from 'Preventing Regulatory Capture: Special Interest Influence, and How to Limit It'

D. Carpenter, D. Moss, Melanie Wachtell Stinnett, 2012 .

The Strength of Strong Ties

D. Lazer, K. Esterling, D. Carpenter, 2003 .

List of abbreviations and acronyms

D. Carpenter, 2014, Language Policy and Planning for the Modern Olympic Games.

The forging of bureaucratic autonomy : reputations, networks, and policy innovation in executive agencies, 1862-1928

Daniel Carpenter, D. Carpenter, 2001 .

Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator

D. Carpenter, 2004, American Political Science Review.

Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA

Daniel Carpenter, D. Carpenter, 2014 .

A Theory of Approval Regulation

Michael M. Ting, D. Carpenter, 2004 .

The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry

D. Carpenter, 2019, Journal of Health Politics, Policy and Law.

A unique researcher identifier for the Physician Payments Sunshine Act.

D. Carpenter, S. Joffe, 2011, JAMA.

A Political Clearinghouse ? Organizational and Presidential Effects in OIRA Review

D. Carpenter, J. Gubb, 2015 .

Approval Regulation and the Endogenous Provision of Confidence : Theory and an Analogy between Financial and Safety Regulation

Justin Grimmer, D. Carpenter, Eric Lomazoff, 2009 .

The complications of controlling agency time discretion: FDA review deadlines and postmarket drug safety.

D. Carpenter, Clayton Nall, Susan L. Moffitt, 2012, American journal of political science.

A Review of: “Madison's Managers: Public Administration and the Constitution by Anthony M. Bertelli and Laurence E. Lynn, Jr.”

D. Carpenter, 2010 .

REGULATORY ERRORS WITH ENDOGENOUS AGENDAS

Michael M. Ting, D. Carpenter, 2007 .

Approval times for new drugs: does the source of funding for FDA staff matter?

A. Fendrick, D. Carpenter, M. Chernew, 2003, Health affairs.

Assessment of US pathway for approving medical devices for rare conditions

A. Kesselheim, D. Carpenter, T. Hwang, 2014, BMJ : British Medical Journal.

US pharmaceutical innovation in an international context.

G. Anderson, P. Hebert, D. Carpenter, 2010, American journal of public health.

Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey

E. Campbell, D. Carpenter, M. Mello, 2017, Journal of General Internal Medicine.

The Downside of Deadlines

Justin Grimmer, D. Carpenter, 2009 .

FDA Transparency in an Inescapably Political World

D. Carpenter, 2017, Journal of Law, Medicine & Ethics.

Paying for innovation: Reimbursement incentives for antibiotics

A. Kesselheim, D. Carpenter, T. Hwang, 2015, Science Translational Medicine.

Can expedited FDA drug approval without expedited follow-up be trusted?

D. Carpenter, 2014, JAMA internal medicine.

A proposal for financing postmarketing drug safety studies by augmenting FDA user fees.

D. Carpenter, 2005, Health affairs.

Preventing Regulatory Capture: Corrosive Capture? The Dueling Forces of Autonomy and Industry Influence in FDA Pharmaceutical Regulation

D. Carpenter, D. Moss, 2013 .

Inequality in Administrative Democracy: Large-Sample Evidence from American Financial Regulation PRELIMINARY DRAFT - DO NOT CITE

D. Carpenter, 2022 .

Inequality in Administrative Democracy: Methods and Evidence from Financial Rulemaking

D. Carpenter, Devin Judge-Lord, 2022 .

The Petition as a Recruitment Device: Evidence from the Abolitionists' Congressional Campaign

D. Carpenter, 2003 .

Petitions and Legislative Committee Formation: Theory and Evidence from Revolutionary Virginia and the Early U.S. House∗

D. Carpenter, Benjamin Schneer, M. Mckinley, 2017 .

The Corporate Metaphor and Executive Department Centralization in the United States, 1888–1928

D. Carpenter, 1998, Studies in American Political Development.

Strategic Realism, not Optimism: Bayesian and Indigenous Perspectives on the Democratizing Petition

D. Carpenter, 2022, Social Science History.

Paths of Recruitment: Rational Social Prospecting in Petition Canvassing

D. Carpenter, Clayton Nall, Benjamin Schneer, 2016 .

Recruitment by Petition: American Antislavery, French Protestantism, English Suppression

Daniel Carpenter, D. Carpenter, 2016, Perspectives on Politics.

When Canvassers Became Activists: Antislavery Petitioning and the Political Mobilization of American Women

D. Carpenter, Colin D. Moore, 2014, American Political Science Review.

Friends, Brokers, and Transitivity: Who Informs Whom in Washington Politics?

David Lazer, Daniel Carpenter, Kevin M. Esterling, 2004, The Journal of Politics.

Are Close Elections Random

Justin Grimmer, Daniel Carpenter, Justin Grimmer, 2011 .

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results.

Bo Wang, Daniel Carpenter, Jessica M Franklin, 2016, JAMA internal medicine.

Congressional Representation by Petition: Assessing the Voices of the Voteless in a Comprehensive New Database, 1789–1949

D. Carpenter, Benjamin Schneer, Tobias Resch, 2020 .

Global health security: the wider lessons from the west African Ebola virus disease epidemic

D. Yach, P. Horby, T. Frieden, 2015, The Lancet.

Groups, the Media, Agency Waiting Costs, and FDA Drug Approval

Daniel Carpenter, D. Carpenter, 2002 .

A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act

E. Campbell, Alison R Hwong, D. Carpenter, 2014, Journal of Law, Medicine & Ethics.

Are Close Elections Random?: Online Appendix

Justin Grimmer, D. Carpenter, Eitan Hersh, 2011 .

Suffrage Petitioning as Formative Practice: American Women Presage and Prepare for the Vote, 1840–1940

D. Carpenter, Benjamin Schneer, Tobias Resch, 2018, Studies in American Political Development.

Volume Information

Christopher, Phillip, James J. Chriss, 1996, American Journal of Sociology.

REGULATORY ERRORS UNDER TWO-SIDED UNCERTAINTY: OR, THE POLITICAL ECONOMY OF VIOXX 1

Michael M. Ting, D. Carpenter, 2005 .

On Categories and the Countability of Things Bureaucratic: Turning From Wilson (Back) to Interpretation

D. Carpenter, 2020 .

Party Formation through Petitions: The Whigs and the Bank War of 1832–1834

D. Carpenter, Benjamin Schneer, 2015, Studies in American Political Development.

Reputation and Power

D. Carpenter, 2014 .

Reputation and Public Administration

Daniel Carpenter, D. Carpenter, George A. Krause, 2012 .

Drug-review deadlines and safety problems.

J. Avorn, D. Carpenter, E. Zucker, 2008, The New England journal of medicine.

Effect of the public disclosure of industry payments information on patients: results from a population-based natural experiment

D. Carpenter, M. Mello, L. Lehmann, 2019, BMJ Open.

Political Learning from Rare Events: Poisson Inference, Fiscal Constraints, and the Lifetime of Bureaus

Daniel Carpenter, David E. Lewis, D. Carpenter, 2004, Political Analysis.

Bioequivalence: The Regulatory Career of a Pharmaceutical Concept

D. Carpenter, Dominique Tobbell, 2011, Bulletin of the history of medicine.

Transactional Authority and Bureaucratic Politics

D. Carpenter, George A. Krause, 2015 .

Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration

D. Carpenter, 2010, Perspectives on Politics.

Crisis and the Emergence of Economic Regulation: The Food, Drug and Cosmetic Act of 1938

D. Carpenter, Gisela Sin, 2002 .

Data and methods for analyzing special interest influence in rulemaking

D. Carpenter, Brian Libgober, Devin Judge-Lord, 2020, Interest Groups & Advocacy.

Lobbying with Lawyers: Financial Market Evidence for Banks’ Influence on Rulemaking

D. Carpenter, Brian Libgober, 2018 .

Executive Power in American Institutional Development

Keith E. Whittington, D. Carpenter, 2003, Perspectives on Politics.

Is Health Politics Different

Daniel Carpenter, D. Carpenter, 2012 .

Substantial Equivalence Standards in Tobacco Governance: Statutory Clarity and Regulatory Precedent for the FSPTCA.

G. Connolly, D. Carpenter, L. Lempert, 2017, Journal of health politics, policy and law.

The political economy of FDA drug review: processing, politics, and lessons for policy.

D. Carpenter, Daniel P Carpenter, 2004, Health affairs.

Information Disclosure and the Physician Payments Sunshine Act—Reply

D. Carpenter, S. Joffe, 2011 .

Agenda Democracy

D. Carpenter, 2022, Annual Review of Political Science.

The Political Foundations of Bureaucratic Autonomy: A Response to Kernell

D. Carpenter, 2001, Studies in American political development.

SEC capture by revolving door: strengths and weaknesses in the evidence base

Daniel Carpenter, Laurence Tai, D. Carpenter, 2014 .

The Forging of Bureaucratic Autonomy

D. Carpenter, 2020 .

Policy Tragedy and the Emergence of Regulation: The Food, Drug, and Cosmetic Act of 1938

D. Carpenter, Gisela Sin, 2007, Studies in American Political Development.

The Forging of Bureaucratic Autonomy: Networks, Reputations and Policy Innovation in Executive Agencies, 1862- 1928

Daniel Carpenter, D. Carpenter, 2001 .

State Building through Reputation Building: Coalitions of Esteem and Program Innovation in the National Postal System, 1883–1913

D. Carpenter, 2000, Studies in American Political Development.

The Multiple and Material Legacies of Stephen Skowronek

D. Carpenter, 2003, Social Science History.

D. Carpenter, Benjamin Schneer, Tobias Resch, 2021, The Journal of Politics.

L’éruption patriote: The Revolt against Dalhousie and the Petitioning Explosion in Nineteenth-Century French Canada

D. Carpenter, Doris Brossard, 2019, Social Science History.

A Formal Model of Learning and Policy Diffusion

Michael M. Ting, D. Carpenter, C. Volden, 2008, American Political Science Review.

“Centralization and the Corporate Metaphor in Executive Departments 1880-1928”

D. Carpenter, 1998 .

Reputation and precedent in the bevacizumab decision.

A. Kesselheim, D. Carpenter, S. Joffe, 2011, The New England journal of medicine.

“Robust Action and the Strategic Use of Ambiguity in a Bureaucratic Cohort: FDA Scientists and the Investigational New Drug Regulations of 1963”

D. Carpenter, S. Skowronek, M. Glassman, 2007 .

“Stochastic Prediction and Estimation of Nonlinear Political Durations: An Application to the Lifetime of Bureaus”

D. Carpenter, 2000 .

Tobacco industry response to a ban on lights descriptors on cigarette packaging and population outcomes

G. Connolly, D. Carpenter, H. Alpert, 2017, Tobacco Control.

FDA Drug Review Deadlines: A Safety Concern?

D. Carpenter, Zucker Ej, Avorn J. Drug-review, 2008 .

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians

D. Carpenter, M. Mello, L. Lehmann, 2019, JAMA network open.

Democracy by Petition

D. Carpenter, 2022 .

Early Entrant Protection in U.S. Pharmaceutical Regulation

D. Carpenter, Ryan T. Rynbrandt, 2003 .

Why Do Bigger Firms Receive Faster Drug Approvals

D. Carpenter, Brian D. Feinstein, M. Turenne, 2004 .

Early Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review

Michael M. Ting, D. Carpenter, E. Zucker, 2010 .

The political logic of regulatory error

Michael M. Ting, D. Carpenter, 2005, Nature Reviews Drug Discovery.

Essay: the political logic of regulatory error.

Michael M. Ting, D. Carpenter, 2005, Nature reviews. Drug discovery.

Are Close Elections Randomly Determined

Justin Grimmer, D. Carpenter, Eitan Hersh, 2010 .

Accounting for Financial Innovation and Borrower Confidence in Financial Rule Making: Analogies from Health Policy

D. Carpenter, 2014, The Journal of Legal Studies.

The Evolution of National Bureaucracy in the United States

D. Carpenter, J. Aberbach, M. Peterson, 2005 .

Government and Markets: Confidence Games: How Does Regulation Constitute Markets?

D. Carpenter, 2009 .

A Republic of Statutes: The New American Constitution. By William N. Eskridge, Jr. and John Ferejohn. New Haven: Yale University Press, 2010. 592p. $85.00.

D. Carpenter, 2012, Perspectives on Politics.

FIVE Confidence Games : How Does Regulation Constitute Markets ?

D. Carpenter, 2014 .

Commentary: What Is the Marginal Value of Analytic Narratives ?

D. Carpenter, 2000 .

“The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Case of Katie Couric”

M. Cowen, A. Fendrick, D. Carpenter, 2003 .

Delegating Powers: A Transaction-Cost Approach to Policymaking under Separate Powers. By David Epstein and Sharyn O’Halloran. Cambridge: Cambridge University Press, 1999. 336p. $55.00 cloth, $21.00 paper

D. Carpenter, 2003, Perspectives on Politics.

“Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation”

Justin Grimmer, D. Carpenter, Eric Lomazoff, 2010 .

Assessment of US pathway for approving medical devices for rare conditions

A. Kesselheim, D. Carpenter, T. Hwang, 2014, BMJ : British Medical Journal.

Keeping Tabs on Financial Innovation: Product Identifiers in Consumer Financial Regulation

D. Carpenter, P. McCoy, 2013 .

“Information and Contact-Making in Policy Networks: A Model with Evidence from the U.S. Health Policy Domain”

D. Lazer, K. Esterling, D. Carpenter, 2003 .

The Strength of Weak Ties in Lobbying Networks

David Lazer, Daniel Carpenter, Kevin M. Esterling, 1998 .

THE LEANING TOWER OF “PISA”: PUBLIC IGNORANCE, ISSUE PUBLICS, AND STATE AUTONOMY: REPLY TO DECANIO

D. Carpenter, 2007 .

Government and Markets: Confidence Games: How Does Regulation Constitute Markets?

D. Carpenter, 2009 .

Preventing Regulatory Capture: Contents

D. Carpenter, D. Moss, 2013 .

The Nature of Political Ideology in the Contemporary Electorate

D. Sunshine Hillygus, Caroline J. Tolbert, Andrew D. Martin, 2009 .

Bioequivalence: The Regulatory Career of a Pharmaceutical Concept

D. Carpenter, Dominique Tobbell, 2011, Bulletin of the history of medicine.

A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act

E. Campbell, D. Carpenter, S. Joffe, 2014, Journal of Law, Medicine & Ethics.

Global health security: the wider lessons from the west African Ebola virus disease epidemic

D. Yach, P. Horby, T. Frieden, 2015, The Lancet.